Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivoJi Young Yoo, Balveen Kaur, Jessica Swanner et al.|Neuro-Oncology|2019Cited by 50
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966Tae Jin Lee, Ji Young Yoo, Haroon Quadri et al.|Molecular Cancer Therapeutics|2019Cited by 33
Enhancing Antitumor Efficacy of Heavily Vascularized Tumors by RAMBO Virus through Decreased Tumor Endothelial Cell ActivationMitra Nair, Ji Young Yoo, Maninder Khosla et al.|Cancers|2020Cited by 18
The complex relationship between integrins and oncolytic herpes Simplex Virus 1 in high-grade glioma therapeuticsKimberly Rivera-Caraballo, Ji Young Yoo, Mitra Nair et al.|Molecular Therapy — Oncolytics|2022Cited by 13
Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer TherapyMitra Nair, Ji Young Yoo, Chelsea Bolyard et al.|Cancers|2021Cited by 12